The healthcare industry is governed by an extremely complex framework of federal, state and local laws, rules and regulations, and there continue to be federal and state proposals that would, and actions that do, impose limitations on government and private payments to providers. In addition, there regularly are proposals to increase co-payments and deductibles from program and private patients. Facilities also are affected by controls imposed by government and private payors designed to reduce admissions and lengths of stay. Such controls include what is commonly referred to as “utilization review”. Utilization review entails the review of a patient’s admission and course of treatment by a third party. Historically, utilization review has resulted in a decrease in certain treatments and procedures being performed. Utilization review is required in connection with the provision of care which is to be funded by Medicare and Medicaid and is also required under many managed care arrangements.

Company profile
Ticker
RNVA
Exchange
Website
CEO
Seamus Lagan
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
CollabRx, Inc., TEGAL CORP /DE/
SEC CIK
Corporate docs
Subsidiaries
Medytox Institute of Laboratory Medicine, Inc. • Medical Billing Choices, Inc. • Medytox Diagnostics, Inc. • Rennova Community Health, Inc. • PB Laboratories, LLC • Biohealth Medical Laboratory, Inc. • Alethea Laboratories, Inc. • International Technologies, LLC • EPIC Reference Labs, Inc. • Epinex Diagnostics Laboratories, Inc. ...
IRS number
680370244
RNVA stock data
Investment data
Securities sold
Number of investors
Calendar
15 Aug 22
16 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 126.88K | 126.88K | 126.88K | 126.88K | 126.88K | 126.88K |
Cash burn (monthly) | (no burn) | 6.06K | 166.61K | 618.59K | 19.49K | 532.53K |
Cash used (since last report) | n/a | 9.52K | 261.54K | 971K | 30.6K | 835.92K |
Cash remaining | n/a | 117.36K | -134.66K | -844.13K | 96.28K | -709.04K |
Runway (months of cash) | n/a | 19.4 | -0.8 | -1.4 | 4.9 | -1.3 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Aug 21 | Christopher Eric Diamantis | Common Stock | Other | Acquire J | No | No | 0 | 95,000,000 | 0 | 95,450,000 |
27 Aug 21 | Christopher Eric Diamantis | Series M Convertible Redeemable Preferred Stock Common Stock | Other | Dispose J | No | No | 0 | 570 | 0 | 20,180 |
27 Aug 21 | Christopher Eric Diamantis | Warrants to Purchase Common Stock Common Stock | Other | Acquire J | No | No | 0.007 | 47,500,000 | 332.5K | 47,500,000 |
Institutional ownership, Q2 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0 |
Total shares | 0 |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abuse, bad, behalf, behavioral, favor, Formation, gave, illustrative, infrastructure, introduce, Jun, leveraging, licensure, Myrtle, proceed, Recovery, residential, retroactive, sector, trillion, type
Current reports
8-K
Rennova Health, Inc. Discusses Progress and Plans for Mental and Behavioral Health Division with the Stock Day Podcast
16 Jun 22
8-K
Rennova Health, Inc. Discusses 2021 Financial Results and Company Progress with the Stock Day Podcast
27 Apr 22
8-K
Entry into a Material Definitive Agreement
7 Apr 22
8-K
Rennova Health, Inc. Completes Reverse Stock Split
16 Mar 22
8-K
Rennova Health, Inc. Announces Reverse Stock Split
10 Mar 22
8-K
Entry into a Material Definitive Agreement
1 Feb 22
8-K
Submission of Matters to a Vote of Security Holders
17 Dec 21
8-K
Rennova Health, Inc. Owned Hospital Receives Critical Access Hospital Certification
13 Dec 21
8-K
Entry into a Material Definitive Agreement
8 Nov 21
8-K
Entry into a Material Definitive Agreement
28 Oct 21
Registration and prospectus
D/A
$1.5M in equity / options / securities to be acquired, sold $1.5M, 2 investors
7 Apr 22
D
$1.5M in equity / options / securities to be acquired, sold $1M, 2 investors
17 Mar 22
D/A
$4M in equity / options / securities to be acquired, sold $4M, 2 investors
17 Dec 21
D
$4M in equity / options / securities to be acquired, sold $2M, 2 investors
1 Nov 21
D/A
$1M in equity / options / securities to be acquired, sold $1M, 2 investors
4 Oct 21
D
$1M in equity / options / securities to be acquired, sold $500K, 2 investors
9 Sep 21
D/A
$4M in equity / options / securities to be acquired, sold $4M, 2 investors
13 Aug 21
D/A
$4M in equity / options / securities to be acquired, sold $3M, 2 investors
16 Jul 21
S-1/A
IPO registration (amended)
2 Jul 21
D/A
$4M in equity / options / securities to be acquired, sold $2M, 2 investors
24 May 21
Proxies
DEF 14C
Information statement
16 Dec 21
PRE 14C
Preliminary information
26 Nov 21
DEF 14C
Information statement
7 Oct 21
PRE 14C
Preliminary information
22 Sep 21
DEF 14C
Information statement
16 Jun 21
PRE 14C
Preliminary information
14 May 21
DEF 14C
Information statement
8 May 20
PRE 14C
Preliminary information
12 Mar 20
PRE 14C
Preliminary information
30 Dec 19
DEF 14C
Information statement
16 Jan 19
Other
EFFECT
Notice of effectiveness
26 Jul 21
CORRESP
Correspondence with SEC
20 Jul 21
CORRESP
Correspondence with SEC
1 Jul 21
UPLOAD
Letter from SEC
8 Jun 21
CORRESP
Correspondence with SEC
20 May 21
UPLOAD
Letter from SEC
2 Mar 21
UPLOAD
Letter from SEC
4 Mar 18
CORRESP
Correspondence with SEC
28 Feb 18
UPLOAD
Letter from SEC
21 Feb 18
EFFECT
Notice of effectiveness
24 Sep 17
Ownership
SC 13D/A
Rennova Health / Diamantis Christopher Eric ownership change
30 Sep 21
4
Rennova Health / Christopher Eric Diamantis ownership change
30 Sep 21
4
Rennova Health / Christopher Eric Diamantis ownership change
27 Sep 21
SC 13D
Rennova Health / Diamantis Christopher Eric ownership change
27 Sep 21
SC 13D/A
Rennova Health / Lagan Seamus ownership change
14 Oct 20
SC 13D/A
Rennova Health / Lagan Seamus ownership change
26 Aug 20
SC 13G/A
Rennova Health, Inc.
22 Jan 20
SC 13D/A
Rennova Health, Inc.
24 Oct 19
3
Rennova Health / Jonathan Immordino ownership change
15 Apr 19
SC 13D/A
Rennova Health, Inc.
20 Aug 18
Reddit threads
$RNVA - Rennova Health Inc
16 Aug 22
Daily Plays August 16, 2022
16 Aug 22
Daily Plays July 18, 2022
18 Jul 22
Daily Plays July 16, 2022
16 Jul 22
Daily Plays July 15, 2022
15 Jul 22
Daily Plays July 14, 2022
14 Jul 22
Daily Plays July 13, 2022
13 Jul 22
Daily Plays July 12, 2022
12 Jul 22
Now that most penny stocks dropped quite a bit, which ones are worth taking a look at?
20 Feb 22
$RNVA ((Back in 2000 was trading at over 15TRILLION WITH A T))
31 Jan 22